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Background. The immunosuppressor cyclosporine A (CsA)
presents the nephrotoxicity as its major side effect that is mostly
attributed to a renal vasoconstriction. This may be due to an
excessive generation of vasoconstrictors like reactive oxygen
species (ROS), or due to a reduction of vasodilators such as the
nitric oxide, which in turn, can be caused by increased amounts
of ROS. We evaluated the effect of CsA and the antioxidant N-
acetylcysteine (NAC) on inducible nitric oxide synthase (iNOS)
mRNA expression and nitric oxide synthesis, in rat renal artery
vascular smooth muscle cells (rVSMCs) primary culture.
Methods. In cells treated during 72 hours with CsA
(10 lg/mL), its vehicle (control) (10 lL/mL), Escherichia coli
lipopolysaccharide (LPS) (100 lg/mL), CsA + LPS, NAC
(6.13 mmol/L), or CsA + NAC, we determined the nitric oxide
synthesis (Griess and chemiluminescence methods), iNOS ex-
pression [reverse transcription-polymerase chain reaction (RT-
PCR)] and cell viability (acridine orange method).
Results. In rVSMCs, LPS increased nitric oxide and iNOS
expression; CsA decreased basal and LPS-induced nitric oxide
and iNOS expression; NAC increased nitric oxide and blunted
the nitric oxide reduction caused by CsA, with no effect on
iNOS. CsA reduced cell viability.
Conclusion. In this study, CsA reduced nitric oxide synthesis
in rVSMCs, both through iNOS down-regulation and reduction
of cell viability, which could be responsible for the vasocon-
strictive effect of the CsA. In the effect of CsA on nitric oxide,
probably a role is also played by free radical production, as this
effect was blunted by NAC.
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Cyclosporine A (CsA) is a powerful immunosuppres-
sive agent, widely used in the prevention and treatment
of organ transplant rejection episodes [1]. However, the
clinical application of CsA is limited due to its several
side effects, and among them nephrotoxicity is one of the
most important. The nephrotoxicity is attributed to an in-
tense vasoconstriction caused by CsA [2] which could be
due to an increased production of vasoconstrictors like
reactive oxygen species (ROS) or due to a reduction in
vasodilators such as the nitric oxide.
Nitric oxide is produced by most cells of the human
body and has as its substrate the L-arginine, which un-
der the effect of nitric oxide synthase (NOS) generates
L-citrulline and nitric oxide, that is metabolized to ni-
trite (NO2−) and nitrate (NO3−) [3, 4]. NOS presents
two isoforms: the constitutive (cNOS) and the inducible
(iNOS); iNOS can be induced by simple agents as, for in-
stance, lipopolysaccharide (LPS), that is associated with
the induction of sepsis [5]. There is evidence that LPS
stimulates cytokine formation in macrophages, leading
to an increased production of nitric oxide [6]. However, a
mechanism independent of cytokines or perhaps a direct
effect of LPS is suggested in studies using isolated rat aor-
tic rings [7], LLC-PK1 cells [8], or vascular smooth muscle
cells (VSMCs) in culture [9], where no leukocytes were
present, yet the cells produced nitric oxide in response to
this drug.
It has been demonstrated that nitric oxide participates
in the regulation of renal blood flow through its vasodila-
tory effects on the renal artery, and in the regulation of
glomerular filtration, acting on the glomerular ultrafiltra-
tion coefficient [10].
Many studies indicate the participation of nitric oxide
as a regulator of renal hemodynamics, its altered synthesis
being related to ischemic [11] or nephrotoxic [12] acute
renal failure (ARF).
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In rat renal mesangial cells exposed to CsA it was ob-
served a suppression of interleukin-1b (IL-1b) induced
expression of NOS [13].
Currently, a great participation in cell injury has also
been attributed to an excessive production of ROS and
several drugs known as antioxidants were already demon-
strated to prevent such injuries. Among these drugs, N-
acetylcysteine (NAC), a thiol of low molecular weight,
stands out regarding removal of free radicals [14].
DiMari et al [15] observed that NAC improves ischemic
renal failure, and although these authors did not know
which was the mechanism of action of NAC in this pro-
cess, they believe that it could be due to both its antioxi-
dant effect and a possible interaction between NAC and
nitric oxide.
Therefore, in spite of the known nephrotoxic effect of
CsA, a local action of this drug on the renal artery, along
with a possible relationship between this and the synthesis
of nitric oxide, are not enough elucidated yet.
The aim of the present study was to evaluate the effect
of CsA and NAC on iNOS mRNA expression and nitric
oxide synthesis in rat renal artery vascular smooth muscle
cells (rVSMCs) primary culture.
METHODS
rVSMCs
Wistar male rats weighing 250 to 300 g were anes-
thetized with a mixture of ketamine (80 mg/kg) and xy-
lazine (10 mg/kg), by intraperitoneal injection [16]. The
kidneys were isolated through an abdominal incision and
the renal arteries were removed and washed in cold
phosphate-buffered saline (PBS). We used the “explant”
technique for smooth muscle cell primary culture.
The cells were grown in 25 cm2 culture flasks, in
Dulbecco’s modified Eagle’s medium (DMEM) with
NaHCO3 (2 g/L), Hepes (2.6 g/L), and penicillin
(10.000 IU/L) supplemented with 20% fetal bovine serum
(FBS) and incubated in a humidified atmosphere with 5%
CO2, at 37◦C. After the first passage, DMEM with 10%
FBS was used.
The cells were used in the experiments between the
third and tenth passages. After the semiconfluency was
reached, the medium was replaced by DMEM with 10%
FBS and without phenol red to avoid interference in the
Griess colorimetric method, and the cells were treated
according to the following groups:
Experimental groups
The experimental groups included the following: (1)
control (CTLCsA), 10 lL/mL of olive oil in dimethyl sul-
foxide (DMSO) (1:100), as CsA vehicle; (2) Escherichia
coli lipopolysaccharide (LPS), 100 lg/mL, which was used
as a positive control of nitric oxide production; (3) CsA,
10 lg/mL in DMSO (1:100), used in a 1 mg/mL solution;
(4) CsA + LPS; (5) CTLNAC, 10 lL/mL of water, as NAC
vehicle; (6) NAC, 6.13 mmol/L; and (7) CsA + NAC.
After 72 hours, the cell culture media were collected
and stored at −20◦C for nitric oxide determination. Then,
the cells were lysed with sodium dodecyl sulfate (SDS)
2% and stored at −20◦C for protein determination.
Dose-response curve
A distinct group of cells was treated during 72 hours
with CsA (1, 5, 10, or 50 lg/mL) or NAC (0.61, 6.13, or
61.3 mmol/L) and a group of cells was treated simulta-
neously with 10lg/mL of CsA and NAC at 0.61, 6.13, or
61.3 mmol/L. The dose-response curve of nitric oxide syn-
thesis was obtained through nitric oxide measurement in
the cell culture media.
Time-response curve
The supernatant from the cells treated with CsA
(10 lg/mL) or NAC (6.13 mmol/L), during different pe-
riods of time (24, 48, or 72 hours), was collected and the
nitric oxide synthesis time-response curve was obtained.
Nitric oxide determination
Nitric oxide was determined in the cell culture media
by the Griess colorimetric method [17] and by the chemi-
luminescence method [18].
Griess colorimetric method. Briefly, a vol:vol mix-
ture of 1% sulfanilamide (in 5% H3PO4) and 0.1%
naphthylethylenediamine solution was added to the sam-
ples and the absorbance at 546 nm was measured using
a GENESYS 2 spectrophotometer (Spectronic Instru-
ments, Inc., Rochester, NY, USA). NO2−, one of the sta-
ble metabolites of nitric oxide, was then estimated from
a standard curve constructed using NaNO2.
Chemiluminescence method. We used the Model 280
Nitric Oxide Analyzer (NOATM) from Sievers Instru-
ments, Inc. (Boulder, CO, USA), a high-sensitive detector
for measuring nitric oxide, based on a gas-phase chemi-
luminescent reaction between nitric oxide and ozone:
NO + O3 → NO−2 + O2
NO−2 → NO2 + hv
The emission from electrically excited nitrogen dioxide
is in the red and near-infrared region of the spectrum, and
it is detected by a thermoelectrically cooled red-sensitive
photomultiplier tube. The sensitivity for measurement of
nitric oxide and its reaction products in liquid samples
is ∼1 picomole.
2510 Lessio et al: CsA and NAC on nitric oxide synthesis in rVSMCs
Intracellular protein
It was measured by the method of Lowry et al [19] and
used as a cell number correction factor in the correspond-
ing culture flasks.
Cell viability
Cellular viability in all experiments was assessed by
the exclusion of the fluorescent dyes acridine orange and
ethidium bromide [20]. After the cells were trypsinized, a
10 lL sample of cell suspension was incubated with 0.3 lL
acridine orange/ethidium bromide solution (100 lL/mL
of each dye). Acridine orange is cell permeable and binds
to either the double-stranded DNA emitting a green
fluorescence (excitation 502 nm and emission 525 nm)
or single-stranded RNA emitting a reddish-orange fluo-
rescence (excitation 460 nm and emission 650 nm). In
contrast, ethidium bromide binds only to the double-
stranded DNA and also emits a red fluorescence (ex-
citation 510 nm and emission 595 nm); however, the
cell is not permeable to the dye when the plasma mem-
brane is intact, and therefore, only necrotic cells will
take up this dye (with the red fluorescence quashing the
green/orange of acridine orange). Cell suspensions were
observed under a fluorescent microscope at 40× magnifi-
cation, and 200 cells from a number of microscopic fields
were counted. Cells emitting a green fluorescence were
considered viable, and those emitting a red fluorescence,
nonviable. Viable cells were expressed as percentage of
the total counted cells.
Reverse transcription-polymerase chain reaction
(RT-PCR) of iNOS
Total RNA was extracted from cultured cells by the
Trizol extraction method. The resulting RNA was used
to generate the cDNA fragment corresponding to the
iNOS by RT-PCR amplification using the primers 5′-CCG
GATCCTCTTTGCTACTGAGACAGG-3′ and 5′-CCG
AATTCGGGATCTGAATGCAATGTT-3′. The cycling
parameters were hot start at 95◦C for 3 minutes, followed
by 40 cycles at 95◦C for 30 seconds, 55◦C for 30 seconds,
72◦C for 30 seconds, 72◦C for 7 minutes, and 4◦C. The
RT-PCR products were resolved on a 3% agarose gel and
visualized by ethidium bromide staining. The housekeep-
ing gene b-actin was used for internal control. The band
density was analyzed by scanning densitometry using im-
age Quant 5.2 (Storm) (Molecular Dynamics, Sunnyvale,
CA, USA).
Statistical analysis
Results were expressed as mean ± standard error
of mean (SEM). To compare nitric oxide between
the groups we used the one-way analysis of variance
(ANOVA). The RT-PCR was quantified by densitome-
try, and the difference in the iNOS/b-actin ratio between
the groups was compared by ANOVA with Tukey’s test.
Statistical significance was defined as P < 0.05.
Chemicals
Acridine orange, copper sulfate, DMEM, folin, Hepes,
LPS (from E. coli serotype O111:B4), NaK-tartrate,
naphthylethylenediamine, ortho-phosphoric acid, ethid-
ium bromide, PBS, penicillin, SDS, sodium bicarbon-
ate, sodium hydroxide, sodium nitrate, sodium nitrite,
sulfanilamide, trypsin-ethylenediaminetetraacetic acid
(EDTA) solution and vanadium were purchased from
Sigma Chemical Company (St. Louis, MO, USA). FBS
was obtained from Gibco BRL (Sa˜o Paulo, Brazil) or
Cultilab (Campinas, Brazil). Ketamine and xylazine were
obtained from Virbac (Sa˜o Paulo, Brazil). Molecular biol-
ogy chemicals, including agarose, bovine serum albumin
(BSA), dithiothreitol (DTT), magnesium chloride solu-
tion, Moloney-murine leukemia virus (M-MLV) reverse
transcriptase, M-MLV RT 5 × reaction buffer, primers,
Taq DNA polymerase, and Trizol reagent, were pur-
chased from Invitrogen Life Technologies (Gaithersburg,
MD, USA). Dietilpirocarbonate (DEPC), ethidium bro-
mide solution, and loading buffer were purchased from
Sigma Chemical Company. Deoxynucleoside triphos-
phate (dNTP) and RNasin were purchased from
Promega Corporation (Madison, WI, USA). Finally,
oligo(dT) primer was purchased from Pharmacia Biotech
(Uppsala, Sweden).
RESULTS
In order to determine the synthesis of the nitric ox-
ide we used two different methods, the Griess and the
chemiluminescence method.
We present the results of nitric oxide synthesis analyzed
by both methods in a cultured rVSMC after treatment
with CsA, LPS, or CsA + LPS, during 72 hours (Table 1).
By the Griess method, we verified that in LPS group there
was an increase of nitric oxide when compared to control
(410 ± 62.1 vs. 18.1 ± 0.5 nmol/mg protein, respectively
(N = 6 for both groups) (P < 0.05). The CsA group (7.3 ±
1.2 nmol/mg protein) (N = 6) (P < 0.05), presented a
significant reduction in the synthesis of nitric oxide when
compared to control and LPS groups. The treatment with
CsA + LPS also caused a significant reduction in nitric
oxide production (78.5 ± 11.7 nmol/mg protein) (N = 6)
(P < 0.05) when compared to LPS group.
By the chemiluminescence method we verified the
same behavior for each group. The LPS group pre-
sented a significant increase in the nitric oxide synthe-
sis when compared to control (2250.1 ± 157.3 vs. 207.9 ±
23 nmol/mg protein, respectively) (N = 6 for both groups)
(P < 0.05). The CsA group showed a significant reduc-
tion when compared to control or LPS groups (78.5 ±
9.2 nmol/mg protein) (N = 6) (P < 0.05). When we used
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Table 1. Nitric oxide synthesis (nmol/mg protein) in cultured rat
renal artery vascular smooth muscle cells (rVSMCs) treated with
cyclosporine A (CsA) (10 lg/mL) and/or lipopolysaccharide (LPS)
(100 lg/mL) during 72 hours
CTLCsA LPS CsA CsA + LPS
Griess 18.1 ± 0.5 410 ± 62.1a 7.3 ± 1.2a,b 78.5 ± 11.7a,b
Nitric oxide 207.9 ± 23 2250.1 ± 157.3a 78.5 ± 9.2a,b 660 ± 78.9a,b
analyzer
N = 6 for all groups; mean ± SEM; one-way analysis of variance (ANOVA)
aP < 0.05 vs. control; bP < 0.05 vs. LPS.
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Fig. 1. Dose-response curve of nitric oxide synthesis (nmol/mg pro-
tein) in cultured rat renal artery vascular smooth muscle cells (rVSMCs)
exposed to cyclosporine A (CsA) (1, 5, 10, or 50 lg/mL) and/or
lipopolysaccharide (LPS) (100 lg/mL) during 72 hours, analyzed by
the chemiluminescence method. Mean ± SEM (N = 6 for all groups).
One-way analysis of variance (ANOVA). #P < 0.05 vs. control; ∗P <
0.05 vs. LPS.
CsA and LPS simultaneously we observed that there was
a reduction in the nitric oxide synthesis when compared
to LPS group (660 ± 78.9 nmol/mg protein)(N = 6) (P <
0.05).
In the dose-response curve of nitric oxide synthesis
(Fig. 1) analyzed by the chemiluminescence method, we
observed a significant nitric oxide increase in LPS group
when compared to control (2250.1 ± 157.3 vs. 207.9 ±
23 nmol/mg protein) (N = 6 for both groups) (P < 0.05).
We observed that CsA at all concentrations (1, 5, 10, or
50 lg/mL) was capable to inhibit the nitric oxide induced
by LPS (429.3 ± 91.2, 382.2 ± 74.9, 346.3 ± 124, and 274 ±
90.5 nmol/mg protein, respectively) (N = 6 for all groups)
(P < 0.05) and this effect increased for each increase of
CsA concentration.
For the time-response curve (Fig. 2), rVSMCs were in-
cubated with CsA (10 lg/mL) and/or LPS (100 lg/mL)
during 24, 48, or 72 hours. We observed that in control
(91.5 ± 8.7, 116.1 ± 42.6, and 207.9 ± 23 nmol/mg protein,
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Fig. 2. Time-response curve of nitric oxide synthesis (nmol/mg protein)
in cultured rat renal artery vascular smooth muscle cells (rVSMCs)
exposed to cyclosporine A (CsA) (10 lg/mL) and lipopolysaccharide
(LPS) or LPS alone (100 lg/mL) during 24, 48, or 72 hours, analyzed by
the chemiluminescence method. Mean ± SEM (N = 6 for all groups).
One-way analysis of variance (ANOVA). #P < 0.05 vs. control (CTL24);
∗P < 0.05 vs. CTL48; &P < 0.05 vs. CTL72; $P < 0.05 vs. LPS24; @P <
0.05 vs. LPS48;
+P < 0.05 vs. LPS72; ×P < 0.05.vs. CsA + LPS24; yP <
0.05 vs. CsA + LPS48.
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Fig. 3. Cellular viability (%) in rat renal artery vascular smooth muscle
cells (rVSMCs) exposed to cyclosporine A (CsA) (10 lg/mL) and/or
lipopolysaccharide (LPS) (100 lg/mL) during 72 hours. Mean ± SEM
(N = 4 for all groups). One-way analysis of variance (ANOVA). #P <
0.05 vs. control; ∗P < 0.05 vs. LPS.
respectively) (N = 6) and LPS (1556.7 ± 146.1, 1663.3 ±
148.7, and 2250.1 ± 157.3 nmol/mg protein, respectively)
(N = 6) the synthesis of nitric oxide increased signifi-
cantly and gradually according to the increase of incu-
bation time. This increase in LPS group was significant
when compared to control at all incubation periods. In
CsA + LPS group (1290.7 ± 66.7, 759.2 ± 60.8, and 660 ±
78.9 nmol/mg protein, respectively) (N = 6), there was
a significant reduction in nitric oxide synthesis, accord-
ing to the incubation time, when compared to LPS at all
periods.
Regarding cellular viability (Fig. 3), the groups CsA
and CsA + LPS presented a significant reduction (78.4 ±
2%, 78.7 ± 0.4%, respectively) (N = 4) (P < 0.05) when
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Fig. 4. Effects of cyclosporine A (CsA) and/or lipopolysaccharide
(LPS) on inducible nitric oxide (iNOS) mRNA expression in rat re-
nal artery smooth muscle cells (rVSMCs). (A) Representative reverse
transcription-polymerase chain reaction (RT-PCR) of four indepen-
dent experiments showing a 464 bp product corresponding to the iNOS
isoform, only in the LPS and CsA + LPS groups. (B) RT-PCR prod-
ucts (191 bp) using the primers for b-actin. Densitometric analysis of
iNOS/b-actin mRNA showed a significant decrease on CsA + LPS
(0.24 ± 0.14 relative densitometric units) compared to LPS group
(0.65 ± 0.12) (P < 0.05).
Table 2. Nitric oxide synthesis (nmol/mg protein) in cultured rat
renal artery vascular smooth muscle cells (rVSMCs) treated with
N-acetylcysteine (NAC) (6.13 mmol/L) + NAC or cyclosporine A
(CsA) (10 lg/mL) during 72 hours, analyzed by the
chemiluminescence method
CTLNAC 204 ± 8.0
NAC 326.8 ± 22.5a
CsA + NAC 365.4 ± 28.6a
N = 7 for all groups. Mean ± SEM; one-way analysis of variance (ANOVA)
aP < 0.05 vs. control.
compared to control (95.5 ± 0.5%) (N = 5) (P < 0.05).
The LPS group showed a cellular viability of 93.8 ± 0.7,
similar to control.
By RT-PCR, there was no detection of iNOS in
rVSMCs treated with CsA, as well as in the control.
However, iNOS mRNA was up-regulated in cells treated
with LPS or CsA + LPS. Densitometric analysis of iNOS
mRNA corrected for b-actin expression (relative densit-
ometric units) of four independent experiments showed
a significant decrease on CsA + LPS compared to LPS
group (0.24 ± 0.14 vs. 0.65 ± 0.12, respectively) (P < 0.05)
(Fig. 4).
We present the results of nitric oxide synthesis obtained
through the chemiluminescence method after treatment
with NAC or CsA + NAC during 72 hours (Table 2).
NAC (326.8 ± 22.5 nmol/mg protein) (N = 7) showed
a significant increase of nitric oxide when compared to
control (204 ± 8.0 nmol/mg protein) (N = 7). When CsA
and NAC were used simultaneously, we also observed
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Fig. 5. Dose-response curve of nitric oxide synthesis (nmol/mg pro-
tein) in cultured rat renal artery vascular smooth muscle cells (rVSMCs)
exposed to N-acetylcysteine (NAC) (0.61, 6.13, or 61.3 mmol/L) during
72 hours, analyzed by the chemiluminescence method. Mean ± SEM.
(N = 7 for all groups). One-way analysis of variance (ANOVA). #P <
0.05 vs. control; ∗P < 0.05 vs. NAC 0.61 mmol/L; $P < 0.05 vs. NAC
6.13 mmol/L.
a significant increase in nitric oxide synthesis (365.4 ±
28.6 nmol/mg protein) (N = 7) comparatively to control.
We show the dose-response curve of nitric oxide syn-
thesis obtained by chemiluminescence method, in cul-
tured rVSMCs treated with different concentrations of
NAC (0.61, 6.13, and 61.3 mmol/L) (Fig. 5). We observed
that NAC is capable to increase the nitric oxide produc-
tion at all concentrations (198 ± 9.5, 300.3 ± 18.0, and
479.4 ± 33.3 nmol/mg protein) (N = 7) when compared
to control (135.1 ± 8.7 nmol/mg protein) (N = 7). Only at
NAC 6.13 and NAC 61.3 mmol/L the nitric oxide increase
was significant when compared to control; at the dose of
61.3 mmol/L, the increase was significant in relation to
6.13 mmol/L.
The time-response curve of nitric oxide synthesis ob-
tained by the chemiluminescence method (Fig. 6), when
rVSMCs were incubated with NAC (6.13 mmol/L) dur-
ing 24, 48, or 72 hours, presented both in controls (102.3
± 4.7, 132.3 ± 4.7, and 195.6 ± 10.7 nmol/mg protein, re-
spectively) (N = 7 for all groups) and NAC groups (128 ±
7.3, 191.7 ± 13, and 326.8 ± 22.5 nmol/mg protein) (N = 7
for all groups) a gradual and significant increase of nitric
oxide at each increase of incubation time.
In the Figure 7 we show the dose-response curve of
nitric oxide synthesis, analyzed by chemiluminescence
method in cultured rVSMCs exposed to NAC (0.61, 6.13,
or 61.3 mmol/L) during 72 hours, in the presence of CsA
(10 lg/mL). We observed that CsA reduced the nitric
oxide synthesis (100.9 ± 14.8 nmol/mg protein) (N = 5)
when compared to control (245.9 ± 21.1 nmol/mg pro-
tein) (N = 5) (P < 0.05). NAC, in all concentrations, in-
creased nitric oxide even in the presence of CsA (301.2 ±
47.5, 388.7 ± 27.4, and 538.1 ± 8.57 nmol/mg protein)
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Fig. 6. Time-response curve of nitric ox-
ide synthesis (nmol/mg protein) in cultured
rat renal artery vascular smooth muscle
cells (rVSMCs) exposed to N-acetylcysteine
(NAC) (6.13 mmol/L) during 24, 48, or
72 hours, analyzed by the chemiluminescence
method. Mean ± SEM (N = 7 for all groups).
One-way analysis of variance (ANOVA).
#P < 0.05 vs. CTL24; ∗P < 0.05 vs. CTL48;
&P < 0.05 vs. CTL72;
+P < 0.05 vs. NAC24;
@P < 0.05 vs. NAC48.
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Fig. 7. Dose-response curve of nitric ox-
ide synthesis (nmol/mg protein) in cultured
rat renal artery vascular smooth muscle
cells (rVSMCs) exposed to N-acetylcysteine
(NAC (0.61, 6.13, or 61.3 mmol/L) in the
presence of cyclosporine A (CsA) (10 lg/mL)
during 72 hours, analyzed by the chemilu-
minescence method. Mean ± SEM (N = 5
for all groups). One-way analysis of variance
(ANOVA). #P < 0.05 vs. control; ∗P < 0.05 vs.
CsA; $P < 0.05 vs. CsA + NAC 0.61 mmol/L;
@P < 0.05 vs. CsA + NAC 6.13 mmol/L.
(N = 5 for all groups) (P < 0.05 vs. control for CsA +
NAC 6.13 and 61.3 mmol/L).
In the cells treated with NAC, there was no expres-
sion of iNOS mRNA, as well as in the control, CsA, and
CsA + NAC groups. On the contrary, in the LPS group,
as previously seen, RT-PCR demonstrated the presence
of iNOS (Fig. 8).
DISCUSSION
The nephrotoxicity caused by CsA, a powerful im-
munosuppressive agent, is a limitant factor for its clinical
use and its pathophysiology is still controversial. In ex-
perimental models it was observed that CsA increases the
renal vascular resistance and decreases the renal blood
flow [21]. In addition, this immunosuppressor induced an
intense constriction of the renal microcirculation, which
was dependent on continuous production of nitric oxide
[2].
Previous reports suggest the participation of nitric
oxide in ischemic ARF since L-arginine, the substrate for
nitric oxide synthesis, had a beneficial effect on the recov-
ery phase of renal failure in rats [22]. However, in other
studies nitric oxide seems to increase the renal injury [23]
probably through its reaction with the superoxide radical
(O2−), generating the very cytotoxic peroxynitrite [24].
Besides, there are no conclusive data yet, regarding the
nitric oxide production in ARF, as some studies show
increased amounts [11, 25, 26] whether others suggest
decreased synthesis of this molecule [12].
In this study we evaluated the expression of iNOS and
the nitric oxide synthesis in cultured rVSMCs treated with
CsA, as well as the influence of the antioxidant NAC on
the nitric oxide production in these cells.
It is known that cells in culture present a very low basal
production of nitric oxide; therefore, we used two meth-
ods for the detection of this molecule: Griess and chemi-
luminescence. Through the chemiluminescence method
we obtained higher values of nitric oxide in relation to
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Fig. 8. Effects of cyclosporine A (CsA), lipopolysaccharide (LPS),
or N-acetylcysteine (NAC) on inducible nitric oxide synthase (iNOS)
mRNA expression in rat renal artery smooth muscle cells (rVSMCs).
(A) Representative reverse transcription-polymerase chain reaction
(RT-PCR) of four independent experiments showing a 464 bp prod-
uct corresponding to the iNOS isoform, only in the LPS group. (B)
RT-PCR products (191 bp) using the primers for b-actin. Densitomet-
ric analysis of iNOS/b-actin mRNA showed (iNOS) mRNA expression
only in the LPS group (0.65 ± 0.12 relative densiometric units).
the Griess method, since the former is considered more
sensitive, as showed for example, by Kanamaru et al [27].
In addition, unlike the Griess method, which only detects
the NO2−, through the chemiluminescence we can detect
both NO2− and NO3−.
In this study we used cultured cells collected from re-
nal arteries. It should be very interesting if VSMCs were
grown from renal arterioles, where CsA probably plays
an important constrictive effect.
The cells treated by CsA presented a significant de-
crease in the nitric oxide production, both by the Griess
and chemiluminescence methods, as compared to con-
trol. The CsA concentrations used in this study, including
the lowest value in the dose-response curve, are above
the therapeutic peak. Previous studies by Meyer-Lehnert
and Schrier [28] showed that 10 lg/mL of CsA was able to
induce VSMC contraction, and in our laboratory, we ob-
served that CsA in the same concentration caused reduc-
tion of nitric oxide synthesis by LLC-PK1 cells in culture
[8]. This decrease of nitric oxide was also observed when
we incubated the cells with CsA + LPS, demonstrating
once again the effect of CsA, which was able to reduce
the LPS-stimulated production of this molecule. When
the cells were exposed to LPS with different concentra-
tions of CsA (dose-response curve), there was a progres-
sive reduction in nitric oxide production when compared
to LPS alone, and from 1 lg/mL of CsA on, this reduc-
tion was already significant. The effect of CsA reducing
the nitric oxide synthesis induced by LPS was also time-
dependent.
A similar effect was reported in the studies of Conde
et al [29] who observed that the CsA inhibited the basal
or the interferon c + LPS stimulated production of NO2−
in cultured macrophages. Nitric oxide inhibition was also
demonstrated in mesangial cells exposed to CsA, by the
evaluation of the IL-1b–induced NOS expression [13]. A
similar effect to that of CsA inhibiting nitric oxide syn-
thesis by a direct action was observed in VSMCs [30] and
also in macrophage culture [31].
Ribeiro et al [9], in our laboratory, showed that
rVSMCs, exposed to different types of radiocontrast,
which are nephrotoxic agents as CsA, presented a reduc-
tion in the synthesis of nitric oxide. Although this effect
on nitric oxide was more pronounced in the cells treated
with the high osmolality ioxitalamate, by using mannitol
they showed that the osmolality was not related to the
nitric oxide reduction.
There are several hypotheses on the mechanism of ac-
tion of CsA in the reduction of nitric oxide synthesis. The
blockade of tumor necrosis factor-a (TNF-a), which is
one of the several stimuli for nitric oxide production [32],
can be one of these mechanisms. This effect is compati-
ble with the decreased nitric oxide production obtained
by Lima et al [8] when they treated the LLC-PK1 cells
with TNF-a and CsA. The reduction in the viability of
LLC-PK1 cells treated with CsA observed by these au-
thors, which was also observed in the rVSMC in our study,
could explain the nitric oxide reduction caused by CsA.
However, the intense reduction in nitric oxide synthesis
(60%) caused by CsA may not be totally explained by
the cellular death caused by this substance, which was of
the order of 18%.
In the present study, we analyzed the iNOS mRNA. In
rVSMCs treated with LPS the expression of iNOS mRNA
was increased when compared to control, but lower in
the CsA + LPS when compared to LPS, which suggests a
blockade of nitric oxide synthesis by CsA, at the transcrip-
tional level. Other factors might be involved, perhaps in
association with the described ones [e.g., the depletion
of a cofactor such as tetrahydrobiopterin, essential in the
mechanism of nitric oxide production, or the nuclear fac-
tor kappaB (NF-jB), which can reduce nitric oxide by
inhibiting the iNOS mRNA transcription].
There is also the possibility that CsA can induce an
excessive formation of the O2−, which reacts with ni-
tric oxide, reducing its levels. Cellular markers suggest-
ing ROS generation and lipid peroxidation were, for
example, detected during ischemia/reperfusion injury
[33]. Shah and Walker [34] demonstrated that in nephro-
toxic ARF caused by glycerol, treatment with N′, N′-
dimethylthiourea (DMTU) and sodium benzoate, an an-
tioxidant that preferentially scavenges hydroxyl radical
(OH−), preserved the renal function. In addition, they
showed that the use of deferoxamine, an iron chelator,
which can block the generation of OH−, protected the
renal function.
Other studies showed that the nephrotoxicity caused
by radiocontrasts can be attenuated by NAC [35, 36], and
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although the mechanism of action of NAC in this process
is still unknown, according to DiMari et al [15] it might
be due to both its antioxidant properties and to a possible
interaction between NAC and nitric oxide.
NAC is a thiol with low molecular weight, with mu-
colytic action, which has an antioxidant effect by remov-
ing free radicals, and it is also responsible for the synthesis
of intracellular glutathione, a natural antioxidant [14].
In our study, when rVSMCs were exposed to NAC,
there was a significant increase in the nitric oxide pro-
duction, which was also observed after incubating these
cells with CsA + NAC, indicating that somehow, NAC
completely prevented the nitric oxide reduction caused
by CsA. We also analyzed the synthesis of iNOS mRNA
after NAC treatment. The iNOS expression was not mod-
ified in rVSMCs treated with NAC, neither with CsA +
NAC. These results suggest that NAC increases the po-
tent vasodilator nitric oxide, through its antioxidant ac-
tion, removing ROS and inhibiting the formation of
peroxynitrite.
CONCLUSION
In our study CsA reduced the nitric oxide production
in rVSMCs, in part by the decrease in cellular viability
and in part due to down-regulation of iNOS mRNA. In
the effect of CsA on nitric oxide, probably a role is also
played by free radical production, as this effect can be
blunted by NAC. The reduced synthesis of nitric oxide
could be related to the vasoconstriction and, therefore,
to the nephrotoxicity caused by this immunosuppressor.
Clinical studies should be undertaken to verify if maneu-
vers to control CsA induced reduction of nitric oxide, in-
cluding the use of NAC, can prevent this nephrotoxicity.
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